July 30, 2025
Vinay Prasad, MD, MPH, director of FDA’s Center for Biologics Evaluation and Research (CBER), departed the agency after less than three months, according to reports from multiple sources. A spokesperson from the U.S. Department of Health and Human Services confirmed his departure to Endpoint News on Tuesday.
On Wednesday, STAT News reported that George F. Tidmarsh, MD, PhD, director of the Center for Drug Evaluation and Research, will serve as acting director.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
